Minimally invasive pancreaticoduodenectomy (MIPD), defined as laparoscopic or robotic surgery, has been slow to develop compared with operations on other organs.1 Approximately 100 years after the first pancreaticoduodenectomy, MIPD is found to be safe, have potential oncologic advantages, and has been a large technical advance in our abilities.2,3 Despite continued skepticism, a select group of institutions, including our own, perform MIPD routinely.
Edil BH, Schulick RD. Challenges of Minimally Invasive Pancreas Surgery Growth With Such a High Learning Curve. JAMA Surg. 2015;150(5):423. doi:10.1001/jamasurg.2015.32